Group One Trading’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Group One Trading’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-78,800	Closed	-$2.17M	–	9093
2021 Q2	$2.17M	Buy	78,800 +41,000	+108%	+$806K	﹤0.01%	2562
2021 Q1	$623K	Sell	37,800 -5,700	-13%	-$130K	﹤0.01%	3780
2020 Q4	$802K	Buy	43,500 +41,300	+1,877%	+$739K	﹤0.01%	2839
2020 Q3	$30K	Sell	2,200 -1,300	-37%	-$20K	﹤0.01%	4945
2020 Q2	$63K	Buy	+3,500	New	+$52.8K	﹤0.01%	4217

Group One Trading's TBIO Position: Q3 2021 in Review

Group One Trading sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 15,321 shares — an estimated $422K sold.

Group One Trading first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $699K in Q1 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Group One Trading reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Group One Trading sold 15,321 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $422K.
Group One Trading first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Group One Trading's Translate Bio, Inc. Common Stock position peaked at $699K in Q1 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.